A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase (original) (raw)

Nature Genetics volume 10, pages 111–113 (1995)Cite this article

Abstract

Hyperhomocysteinaemia has been identified as a risk factor for cerebrovascular, peripheral vascular and coronary heart disease1–4. Elevated levels of plasma homocysteine can result from genetic or nutrient-related disturbances in the trans-sulphuration or re-methylation pathways for homocysteine metabolism1,5–7. 5,10-Methylenetetrahydrofolate reductase (MTHFR) catalyzes the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetra-hydrofolate, the predominant circulatory form of folate and carbon donor for the re-methylation of homocysteine to methionine. Reduced MTHFR activity with a thermolabile enzyme has been reported in patients with coronary and peripheral artery disease5,6. We have identified a common mutation in MTHFR which alters a highly-conserved amino acid; the substitution occurs at a frequency of approximately 38% of unselected chromosomes. The mutation in the heterozygous or homozygous state correlates with reduced enzyme activity and increased thermolability in lymphocyte extracts; in vitro expression of a mutagenized cDNA containing the mutation confirms its effect on thermolability of MTHFR. Finally, individuals homozygous for the mutation have significantly elevated plasma homocysteine levels. This mutation in MTHFR may represent an important genetic risk factor in vascular disease.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Boers, G.H.J. et al. Heterozygosity for homocystinuria in premature peripheral and cerebral ocelusive arterial disease. New Engl. J. Mod. 313, 709–715 (1985).
    Article CAS Google Scholar
  2. Genest, J.J. Jr., et al. Plasma homocysteine levels in men with premature coronary artery disease. J. Am. coll. Cartiiol. 16, 1114–1119 (1990).
    Article Google Scholar
  3. Clarke, R. et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. New Engl. J. Med. 324, 1149–1155 (1991).
    Article CAS Google Scholar
  4. Stampfer, M.J. et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J. Am. med. Assoc. 268, 877–881 (1992).
    Article CAS Google Scholar
  5. Kang, S.-S. et al. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am. J. hum. Genet. 48, 536–645 (1991).
    CAS PubMed PubMed Central Google Scholar
  6. Engbersen, A.M.T. et al. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinaemia. Am. J. hum. Genet. 56, 142–150 (1995).
    CAS PubMed PubMed Central Google Scholar
  7. Selhub, J., Jacques, P.F., Wilson, P.W.F., Rush, D. & Rosenberg, I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Am. med. Assoc. 270, 2693–2698 (1993).
    Article CAS Google Scholar
  8. Rosenblatt, D.S. in The Metabolic Basis of Inherited Disease (eds Scriver, C.R., Beaudet, A.L, Sly, W.S. & Valle, D.) 2049–2064 (McGraw-Hill, New York, 1989).
    Google Scholar
  9. Kang, S.-S., Passen, E.L., Ruggie, N., Wong, P.W.K. & Sora, H. Thermolabile defect of methytenetetrahydrofolate reductase in coronary artery disease. Circulation 88, 1463–1469 (1993).
    Article CAS Google Scholar
  10. Goyette, P. et al. Human methylenetetrahydrofolate reductase:isolation of cDNA, mapping and mutation identification. Nature Genet. 7, 195–200 (1994).
    Article CAS Google Scholar
  11. Goyette, P., Frosst, P., Rosenblatt, D.S. & Rozen, R. Seven novel mutations in the methylenetetrahydrofolate reductase gene andgenotype/phenotypecorrelations in severe methylenetetrahydrofolate reductase deficiency. Am. J. hum. Genet. 56, 1052–1059 (1995).
    CAS PubMed PubMed Central Google Scholar
  12. Daubner, S.C. & Matthews, R.G. Purification and properties of methylenetetrahydrofolate reductase from pig liver. J. biol. Chem. 257, 140–145 (1982).
    CAS PubMed Google Scholar
  13. Davies, J.F. . et al. Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. J. Biochem. 29, 9467–3479 (1990).
    Article CAS Google Scholar
  14. Franken, D.G., Boers, G.H.J., Blom, H.J., Trijbels, J.M.F. & Kbppenborg, P.W.C. Treatment of mild hyperhomocysteinemia in vasculardisease patients. Arterioscler. Thromb. 14, 465–470 (1994).
    Article CAS Google Scholar
  15. Kang, S.S., Zhou, J., Wong, P.W.K., Kowalisyn, J. & Strokosch, G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am. J. hum. Genet. 43, 414–421 (1988).
    CAS PubMed PubMed Central Google Scholar
  16. Horton, R.M. et al. Gene splicing by overlap extension. Meth. Enzymol. 217, 270–279 (1993).
    Article CAS Google Scholar
  17. Rosenblatt, D.S. & Erbe, R.W. Methylenetetrahydrofolate reductase in cultured human cells. I. Growth and metabolic studies. Pediatr. Res. 11, 1137–1141 (1977).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Departments of Human Genetics, Pediatrics and Biology, McGill University, Montreal Children's Hospital, Montreal, H3H 1P3, Canada
    P. Frosst, R. Milos, P. Goyette & R. Rozen
  2. Department of Pediatrics, University Hospital Nijmegen, Nijmegen, 6500 HB, The Netherlands
    H.J. Blom, M. den Heijer, L.A.J. Kluijtmans & L.P. van den Heuve
  3. Biophysics Research Division and Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, 48109, USA
    C.A. Sheppard & R.G. Matthews
  4. Department of Medicine, University Hospital Nijmegen, Nijmegen, 6500 HB, The Netherlands
    G.J.H. Boers
  5. Department of Hematology, Municipal Hospital Leyenburg, The Hague, 2545 CH, The Netherlands
    M. den Heijer

Authors

  1. P. Frosst
    You can also search for this author inPubMed Google Scholar
  2. H.J. Blom
    You can also search for this author inPubMed Google Scholar
  3. R. Milos
    You can also search for this author inPubMed Google Scholar
  4. P. Goyette
    You can also search for this author inPubMed Google Scholar
  5. C.A. Sheppard
    You can also search for this author inPubMed Google Scholar
  6. R.G. Matthews
    You can also search for this author inPubMed Google Scholar
  7. G.J.H. Boers
    You can also search for this author inPubMed Google Scholar
  8. M. den Heijer
    You can also search for this author inPubMed Google Scholar
  9. L.A.J. Kluijtmans
    You can also search for this author inPubMed Google Scholar
  10. L.P. van den Heuve
    You can also search for this author inPubMed Google Scholar
  11. R. Rozen
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Frosst, P., Blom, H., Milos, R. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.Nat Genet 10, 111–113 (1995). https://doi.org/10.1038/ng0595-111

Download citation

This article is cited by